infecti
respiratori
diseas
domest
fowl
affect
poultri
age
caus
econom
problem
poultri
industri
worldwid
although
ibv
control
use
live
attenu
inactiv
vaccin
continu
major
problem
due
exist
mani
serotyp
determin
surfac
spike
protein
result
poor
crossprotect
loss
immunogen
associ
vaccin
product
live
attenu
ibv
vaccin
produc
repeat
passag
embryon
egg
result
spontan
mutat
consequ
attenu
virus
mutat
respons
loss
virul
differ
vaccin
affect
virul
andor
immunogen
revert
virul
new
gener
vaccin
call
one
mean
control
ibv
involv
develop
new
safer
vaccin
precis
modifi
ibv
genom
use
revers
genet
product
ration
attenu
ibv
order
obtain
optimum
balanc
loss
virul
capac
induc
immun
infecti
bronchiti
ib
acut
highli
contagi
respiratori
diseas
poultri
preval
throughout
world
caus
anim
welfar
issu
sever
econom
loss
poultri
industri
worldwid
etiolog
agent
ib
avian
coronaviru
infecti
bronchiti
viru
ibv
belong
gammacoronaviru
genu
subfamili
coronavirina
famili
coronavirida
order
nidoviral
ibv
replic
primarili
epitheli
cell
respiratori
tract
caus
ib
character
nasal
discharg
snick
tracheal
ciliostasi
rale
chicken
also
abl
replic
epitheli
cell
organ
enter
tract
oviduct
kidney
main
effect
ibv
infect
poor
weight
gain
renal
diseas
decreas
egg
product
poor
egg
qualiti
result
major
econom
loss
poultri
industri
worldwid
ibv
genom
consist
kb
singlestrand
rna
molecul
positivesens
polar
virion
contain
four
structur
protein
spike
glycoprotein
small
membran
protein
e
integr
membran
protein
nucleocapsid
protein
n
interact
genom
rna
glycoprotein
type
glycoprotein
compos
three
homopolym
respons
bind
target
cell
receptor
fusion
viral
cellular
membran
ibv
glycoprotein
amino
acid
cleav
two
subunit
amino
acid
kda
compris
ntermin
subunit
protein
amino
acid
kda
compris
ctermin
subunit
subunit
incorpor
receptorbind
activ
protein
respons
induc
neutral
serospecif
antibodi
ectodomain
region
subunit
contain
fusion
peptidelik
region
two
heptad
repeat
region
involv
oligomeris
protein
requir
entri
suscept
cell
subunit
associ
noncoval
subunit
addit
ectodomain
contain
transmembran
ctermin
cytoplasm
tail
domain
ibv
current
control
use
live
attenu
inactiv
boost
vaccin
neutralis
antibodi
induc
ibv
subunit
present
respiratori
tract
respons
protect
subsequ
ibv
infect
concomit
ib
diseas
howev
amino
acid
variat
subunit
result
mani
differ
ibv
serotyp
requir
differ
vaccin
due
lack
crossprotect
commerci
live
attenu
vaccin
produc
multipl
passag
virul
field
isol
embryon
domest
fowl
egg
result
spontan
mutat
caus
attenu
viru
consequ
virus
attenu
approach
mutat
respons
loss
virul
due
natur
procedur
attenu
virus
differ
mutat
may
affect
virul
andor
immunogen
process
requir
fine
balanc
loss
pathogen
retent
immunogen
mutat
result
attenu
pathogen
known
major
drawback
method
viru
use
inocul
chicken
mutat
result
attenu
vaccin
viru
may
backmut
result
virul
viru
undesir
consequ
although
use
live
attenu
ibv
vaccin
play
import
role
success
expans
poultri
industri
exist
continu
introduct
new
ibv
serotyp
requir
altern
strategi
order
circumv
problem
poor
crossprotect
product
safer
vaccin
new
gener
ib
vaccin
call
one
mean
control
ibv
involv
develop
new
safer
vaccin
precis
modifi
ibv
genom
product
ration
attenu
ibv
obtain
optimum
balanc
loss
virul
capac
induc
immun
vaccin
would
ideal
genet
stabl
defin
uniform
stabl
attenu
phenotyp
unabl
back
mutat
virul
potenti
uniform
immunogen
loss
virul
affect
immunogen
flexibl
modifi
genom
manipul
express
differ
gene
subunit
allow
genet
defin
vaccin
protect
differ
serotyp
allow
administr
ovo
ibv
vaccin
gener
passag
embryon
egg
highli
virul
embryo
ovo
applic
use
ibv
genom
precis
modifi
use
suitabl
revers
genet
system
develop
revers
genet
system
infecti
clone
manipul
ibv
genom
modifi
ibv
genom
exchang
glycoprotein
gene
gene
deriv
virul
ibv
strain
introduc
genom
attenu
ibv
result
recombin
ibv
still
avirul
abl
act
vaccin
protect
chicken
challeng
parent
virul
virus
gene
deriv
result
demonstr
use
revers
genet
system
swap
ibv
protein
precis
effect
way
gener
genet
defin
candid
ibv
vaccin
recent
paper
plo
one
shown
replac
ibv
glycoprotein
pathogen
field
isol
ibv
uk
belong
differ
serotyp
receiv
ibv
beaudett
confer
pathogen
induc
homolog
protect
confirm
previou
work
journal
virolog
glycoprotein
use
deriv
ibv
belong
serotyp
receiv
viru
ibv
beaudett
result
involv
replac
ibv
glycoprotein
gene
demonstr
avail
ibv
revers
genet
system
open
way
modifi
ibv
genom
develop
new
genet
defin
intrins
safer
ibv
vaccin
revers
genet
system
use
modifi
ibv
genom
compris
two
process
first
outlin
figur
involv
direct
modif
ibv
genom
second
process
outlin
figur
center
recoveri
infecti
ibv
fulllength
ibv
cdna
deriv
genom
rna
avirul
beaudett
strain
sequenti
assembl
vitro
ligat
noti
site
thymidin
kinas
tk
gene
vaccinia
viru
fig
use
templat
modifi
ibv
beaudett
genom
ibv
cdna
control
bacteriopahg
dna
depend
rna
polymeras
promot
hepat
delta
viru
ribozym
hdr
sequenc
place
downstream
coronaviru
poli
tail
follow
dna
depend
rna
polymeras
termin
sequenc
fig
work
describ
journal
virolog
plo
one
paper
describ
replac
beaudett
gene
correspond
process
insert
heterolog
gene
modifi
version
fulllength
ibv
cdna
lack
beaudett
gene
sequenc
new
gene
sequenc
insert
gpt
select
plasmid
flank
beaudettederiv
sequenc
correspond
sequenc
delet
gene
sequenc
potenti
singlestep
homolog
recombin
event
end
replicas
gene
receiv
ibv
cdna
flank
sequenc
donor
sequenc
gpt
plasmid
shown
result
seri
recombin
vaccinia
virus
select
due
gpt
phenotyp
presenc
mpa
growth
gpt
recombin
vaccinia
viru
absenc
mpa
give
rise
two
type
spontan
intramolecular
recombin
event
due
presenc
tandem
repeat
sequenc
ibv
cdna
recombin
vaccinia
viru
result
gener
recombin
vaccinia
virus
either
ibv
cdna
without
gene
modif
complet
fulllength
ibv
cdna
contain
heterolog
gene
desir
end
product
recombin
event
result
loss
gpt
gene
ibv
gene
repres
structur
accessori
gene
shown
potenti
recombin
event
indic
ibv
replicas
gene
sequenc
common
construct
gene
sequenc
pathogen
ibv
strain
uk
respect
highlight
figur
order
make
alter
exchang
gene
ibv
beaudett
genom
ibv
cdna
within
vaccinia
viru
genom
modifi
homolog
recombin
use
vaccinia
virusbas
transdomin
select
td
method
procedur
describ
recent
plo
one
paper
insert
glycoprotein
gene
ibv
uk
beaudett
genom
background
summar
figur
first
stage
consist
singl
step
homolog
recombin
event
donor
ibv
cdna
sequenc
ibv
uk
gene
sequenc
insert
e
coli
guanin
phosphoribosyltransferas
gpt
contain
plasmid
receiv
ibv
sequenc
modifi
version
ibv
beaudett
fulllength
genom
cdna
lack
beaudett
gene
sequenc
vaccinia
viru
genom
homolog
recombin
event
occur
one
two
beaudettederiv
sequenc
flank
either
end
heterolog
uk
gene
sequenc
correspond
beaudett
sequenc
present
delet
gene
sequenc
receiv
ibv
cdna
result
integr
complet
plasmid
sequenc
receiv
ibv
cdna
allow
select
recombin
vaccinia
virus
presenc
mycophenol
acid
mpa
mpa
inhibitor
purin
biosynthesi
therefor
virus
express
e
coli
gpt
gene
provid
altern
pathway
purin
biosynthesi
abl
replic
presenc
mpa
altern
purin
precursor
xanthin
hypoxanthin
randomli
select
gpt
virus
grown
absenc
mpa
result
second
intern
recombin
event
tandem
repeat
ibv
sequenc
caus
loss
e
coli
gpt
gene
viru
gener
p
ck
cell
analyz
presenc
modif
use
subsequ
experi
fig
second
recombin
step
led
two
possibl
outcom
one
event
result
origin
unmodifi
ibv
sequenc
desir
modif
gener
ibv
cdna
contain
uk
gene
sequenc
beaudett
cdna
lack
beaudett
gene
sequenc
fig
recombin
vaccinia
virus
longer
express
gpt
gene
isol
sequenc
analysi
use
identifi
contain
uk
gene
sequenc
infecti
ibv
rna
gener
situ
transfect
vaccinia
viru
dna
contain
modifi
beaudett
cdna
primari
chick
kidney
ck
cell
previous
infect
recombin
fowlpox
viru
express
rna
polymeras
outlin
figur
system
infecti
ibv
rna
produc
promot
immedi
adjac
end
ibv
cdna
rna
polymeras
termin
termin
sequenc
downstream
hdr
sequenc
autocleav
sequenc
end
poli
sequenc
result
authent
copi
ibv
genom
rna
cell
supernat
transfect
ck
cell
filter
remov
potenti
recombin
ibv
passag
three
time
ck
cell
fig
produc
stock
viru
sequenc
analysi
confirm
presenc
modifi
ibv
sequenc
also
found
use
glycoprotein
field
isol
ibv
uk
adapt
growth
primari
ck
cell
unabl
recov
infecti
viru
use
ck
cell
due
fact
potenti
viru
refractori
growth
ck
cell
circumv
perform
initi
rescu
recombin
ibv
ck
cell
instead
passag
potenti
ibv
filter
supernat
ck
cell
perform
embryon
egg
result
recombin
ibv
apart
modif
isogen
deriv
cdna
sequenc
indic
success
introduc
two
differ
heterolog
gene
sequenc
ibv
beaudett
genom
background
recov
infecti
recombin
ibv
use
revers
genet
system
recombin
ibv
found
cell
tropism
associ
heterolog
gene
sequenc
assess
potenti
ibv
vaccin
candid
three
week
primari
inocul
either
chicken
challeng
pathogen
ibv
uk
respect
clinic
sign
associ
pathogen
ibv
infect
observ
vaccin
chicken
indic
protect
clinic
diseas
challeng
homolog
pathogen
viru
demonstr
homolog
protect
induc
appropri
recombin
ibv
interestingli
result
prior
inocul
chicken
recombin
ibv
subsequ
challeng
ibv
differ
serotyp
ibv
uk
indic
experiment
condit
induc
level
cross
protect
accord
analysi
clinic
sign
unabl
isol
viabl
ibv
detect
ibvderiv
rna
tracheal
cell
vaccin
chicken
follow
challeng
either
pathogen
viru
indic
recombin
virus
use
vaccin
chicken
prior
challeng
induc
protect
respons
prevent
pathogen
virus
success
infect
tracheal
cell
viru
ibvderiv
rna
isol
trachea
chicken
vaccin
conclus
shown
use
ibv
revers
genet
system
replac
ibv
beaudett
glycoprotein
gene
sequenc
pathogen
ibv
uk
confer
virul
recombin
ibv
result
virus
tissu
tropism
associ
parent
uk
virus
chicken
vaccin
found
protect
clinic
diseas
follow
challeng
uk
wherea
chicken
vaccin
beaudett
protect
challeng
beaudett
isol
ibv
attenu
sever
hundr
passag
embryon
hen
egg
result
loss
virul
also
implic
loss
immunogen
result
shown
replac
beaudett
gene
heterolog
gene
two
differ
ibv
serotyp
result
recombin
ibv
base
beaudett
genom
abl
act
potenti
vaccin
protect
chicken
follow
subsequ
challeng
parent
pathogen
virus
swap
ibv
protein
precis
effect
way
gener
genet
defin
candid
ibv
vaccin
